DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chen L, Wu N, Kennedy L. et al.
Inhibition of secretin/secretin receptor axis ameliorates non-alcoholic fatty liver disease phenotypes.
Hepatology 2021; In press
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.